Skip to content
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboardSign in
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboard
Sign in
Transparency
  • Company
  • Our clinicians
  • Pharmacy partners
  • Where we operate
  • Accreditation
Legal
  • Terms of Service
  • Privacy Policy
  • Notice of Privacy Practices
  • Telehealth Consent
  • Auto-Renewal Terms
  • Refund & Shipping
  • Pharmacy Disclosure
  • Prescribing Policy
  • Patient Rights & Nondiscrimination
  • Texas Medical Board Complaint Notice
  • SMS Terms
  • Cookies
  • California Privacy
  • Accessibility
Support
  • support@upliftrx.co
  • Member sign in

Medical emergency? Call 911. In crisis? Call or text 988 (Suicide & Crisis Lifeline). UpLiftRX is not for emergencies.

Prescription products require an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Available to adults 18+ in states where our clinicians are licensed.

Compounded medications are prepared by state-licensed pharmacies for an individual patient and are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.

Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX provides a technology platform and is not a pharmacy or a medical provider. Medical services are provided by independent, licensed clinicians of a professional medical group (being finalized). Prescriptions are dispensed by independent, state-licensed pharmacies. Latitude Investments Management Ltd. Liability Co., a Wyoming limited liability company (filing no. 2024-001499647), 5709 Gardendale Dr, STE D, Houston, TX 77092.

Wegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Zepbound® and Cialis® are registered trademarks of Eli Lilly and Company. Contrave® is a registered trademark of Currax Pharmaceuticals LLC. Viagra® is a registered trademark of Viatris Specialty LLC. All trademarks are the property of their respective owners. UpLiftRX is not affiliated with or endorsed by any drug manufacturer, and generic medications are not the brand-name products.

© 2026 Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX.
  1. Home/
  2. Medications/
  3. Wellness/
  4. Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium
Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness

Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule

Capsule

Naltrexone / Yohimbine / Caffeine / DHEA / Cyanocobalamin / Methionine / Inositol / Chromium, 8 mg/2.5 mg/25 mg/10 mg/0.5 mg/25 mg/25 mg/100 mcg. The prescriber sets the dose.

$130/ month· visit, medication & shipping · charged only if prescribed
Specification
Just this one: start consultation

Add several treatments and check out once. $0 today; each is charged only if prescribed.

Rx only · adults 18+. Requires an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Compounded medications are prepared by a state-licensed pharmacy and are not FDA-approved.

Know before you start

How Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium treatment works

How it works

Wellness and sleep protocols pair targeted prescriptions and micronutrient injectables — like NAD+, methylated B-complex, glutathione, and circadian-supporting compounds — to address the biochemical side of energy, recovery, and sleep quality.

What to expect

  • Your clinician matches the protocol to your goal and screens for interactions.
  • Effects build over weeks; injectables are typically dosed 1–3× weekly.
  • Adjustments at monthly check-ins based on your response.

Common side effects

  • Injection-site soreness
  • Flushing or nausea if dosed too quickly (NAD+)
  • Vivid dreams or grogginess while titrating sleep support

Safety & who it's not for

Tell your clinician about all medications and supplements you take. Wellness compounds are compounded preparations and are not FDA-approved as finished products.

Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium FAQ

What is Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium?

Naltrexone / Yohimbine / Caffeine / DHEA / Cyanocobalamin / Methionine / Inositol / Chromium, 8 mg/2.5 mg/25 mg/10 mg/0.5 mg/25 mg/25 mg/100 mcg. The prescriber sets the dose. It is compounded for you by a state-licensed 503A pharmacy and is not FDA-approved.

How much does Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium cost?

Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium starts at $130 per month through UpLiftRX. The price includes the online clinician visit, the medication, and shipping. Your card is charged only if a licensed clinician prescribes it.

How is Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium taken?

Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium is taken by mouth. Typical pharmacy directions read: "Take 1 capsule (8 mg/2.5 mg/25 mg/10 mg/500 mcg/25 mg/25 mg/100 mcg) by mouth once daily." Your clinician sets your actual dose and schedule, and the pharmacy label on your prescription is what you follow.

Is Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium FDA-approved?

No. Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium is a compounded preparation, and compounded drugs are not FDA-approved. FDA has approved other products that contain naltrexone (for example Contrave Extended-Release, Vivitrol); a compounded version is prepared for an individual patient when a clinician decides it is appropriate.

Do I need a prescription for Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium?

Yes. Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium requires a prescription. Start an online visit, answer the health questionnaire, and a licensed clinician reviews it. If Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium is appropriate, the clinician prescribes it and a licensed pharmacy ships it to you.

How should I store Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium?

Store at room temperature, away from heat and moisture.

Where does Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium ship?

Pharmacies in our network can ship Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium to 42 states (not California). It is not currently available in 9 states; the online visit checks your state first. Orders typically arrive in 2 days after the pharmacy ships, and shipping is included in the price.

What does the research say about Naltrexone?

PubMed indexes 8,940 publications that mention Naltrexone, including 1,217 randomized trials, systematic reviews, or meta-analyses. ClinicalTrials.gov lists 537 registered studies. Study results for FDA-approved products do not transfer automatically to compounded preparations. The sources are linked on this page.

Is this a substitute for sleep hygiene?

No — it's a complement. Your care plan includes the behavioral foundations; the protocol addresses the biochemical side.

How fast will I feel it?

Some members feel a difference within days (B-complex, NAD+); circadian and recovery changes typically take 2–4 weeks of consistency.

Important safety information

Your clinician will review your health history, current medications, and allergies and explain the risks, side effects, and alternatives before prescribing.

Compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness, or quality before they are dispensed. Tell your clinician about all medications and supplements you take. Seek emergency care (call 911) for severe reactions. Report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Similar products

Similar to Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium

See all in Wellness →
Naltrexone HCl + Bupropion HCl oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Naltrexone HCl + Bupropion HCl
8 mg/90 mg ER
Contrave® (naltrexone/bupropion ER) oral, brand-name prescription medication, pharmacy prescription bag illustrationBrand-name · FDA-approved
Appetite Suppressant
Contrave® (naltrexone/bupropion ER)
8mg/90mg
Metformin ER oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Metformin ER
2 options
Sertraline HCl oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Sertraline HCl
2 options
Bupropion oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Bupropion
150 mg SR
Fluoxetine oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Fluoxetine
20 mg
Ivermectin oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Ivermectin
4 options
Ondansetron Oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Ondansetron Oral
4 mg
$130/mo
On this pageOverviewStrengths & pricesHow it's takenStorage & shippingResearch & sourcesFAQReviewsSafety
At a glance

What is Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule?

Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium is a compounded capsule prepared for an individual patient by a state-licensed 503A compounding pharmacy. It is not FDA-approved. Route: by mouth. Through UpLiftRX it costs from $130 per month, including the online visit, the medication, and shipping. You are charged only if a licensed clinician prescribes it. It can ship to 42 states (not California).

Form
Capsule
Route
By mouth
Active ingredients
Naltrexone, Yohimbine, Caffeine, DHEA, Cyanocobalamin, Methionine, Inositol, Chromium
Options
1 strength and size option
Price
$130 per month, visit and shipping included
Prescription
Required. A licensed clinician decides whether it is appropriate.
FDA status
Compounded. Not FDA-approved; FDA does not review compounded drugs before they are dispensed.
Dispensed by
A state-licensed 503A compounding pharmacy
Ships to
42 states (not California)
Storage
Store at room temperature, away from heat and moisture.
Availability
In stock at one or more pharmacies

Product details from our pharmacy network's catalog, updated October 22, 2026.

Strengths & prices

Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule strengths and prices

1 option. Prices are per month and include the online visit, the medication, and shipping; you are charged only if a clinician prescribes it.
StrengthSizePriceAvailability
8 mg/2.5 mg/25 mg/10 mg/0.5 mg/25 mg/25 mg/100 mcg30 capsules$130In stock
How it's taken

How to take Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule

Route and directions

Route: By mouth

Example pharmacy label: “Take 1 capsule (8 mg/2.5 mg/25 mg/10 mg/500 mcg/25 mg/25 mg/100 mcg) by mouth once daily.”

Your clinician sets your dose and schedule. Follow the label on your own prescription, not this example.

Preparation and supplies

Mixing: None. It ships ready to use.

Storage & shipping

Storing and shipping Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule

Storage

Store at room temperature, away from heat and moisture.

Keep out of reach of children. Do not use after the beyond-use date on the label.

Shipping

Ships to 42 states (not California), typically arriving in 2 days after the pharmacy ships. Shipping is included in the price.

States it ships to

Alaska, Arizona, Colorado, Connecticut, Delaware, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia, Wyoming

Clinical research & sources

Research on the ingredients in Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule

Published research and public drug references for each active ingredient, from the U.S. National Library of Medicine (PubMed, MedlinePlus, DailyMed, RxNorm, PubChem), ClinicalTrials.gov, and FDA. These studies are about the ingredients, often in FDA-approved products. None of them tested this compounded preparation, and their results do not automatically apply to it.

Naltrexone

FDA status: FDA has approved products that contain naltrexone, including Contrave Extended-Release, Vivitrol.

PubMed: 8,940 publications mention Naltrexone, 1,217 of them trials or reviews. Search PubMed

  1. Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. McPheeters M et al. JAMA, 2023. Meta-Analysis, Systematic Review. PMID 37934220 · DOI
  2. A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults. McGowan B et al. Nature medicine, 2025. Systematic Review, Network Meta-Analysis. PMID 41039116 · DOI
  3. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. Kim PS et al. Current pain and headache reports, 2020. Systematic Review. PMID 32845365 · DOI
  4. Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis. Bahji A et al. Journal of addiction medicine, 2022. Systematic Review, Network Meta-Analysis. PMID 35653782 · DOI
  5. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis. Ray LA et al. JAMA network open, 2020. Meta-Analysis, Systematic Review. PMID 32558914 · DOI

ClinicalTrials.gov: 537 registered studies. See all studies

  • NCT05037032 Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude (Phase 4), completed
  • NCT05228418 Bridging ED to Outpatient AUD Therapy With Naltrexone (Phase 4), unknown

MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 7243 ↗PubChem CID 5360515 ↗Wikipedia ↗

Yohimbine

FDA status: We found no FDA-approved drug product listing yohimbine as an active ingredient in openFDA.

PubMed: 8,050 publications mention Yohimbine, 189 of them trials or reviews. Search PubMed

  1. Effects of dietary supplements on athletic performance in elite soccer players: a systematic review. Abreu R et al. Journal of the International Society of Sports Nutrition, 2023. Systematic Review. PMID 37462346 · DOI
  2. The Potential Role of Arginine Supplements on Erectile Dysfunction: A Systemic Review and Meta-Analysis. Rhim HC et al. The journal of sexual medicine, 2019. Meta-Analysis, Systematic Review. PMID 30770070 · DOI
  3. Erectile dysfunction. Khera M et al. BMJ clinical evidence, 2011. Systematic Review. PMID 21711956
  4. Effects of Acute Yohimbine Hydrochloride Supplementation on Repeated Supramaximal Sprint Performance. Barnes ME et al. International journal of environmental research and public health, 2022. Randomized Controlled Trial. PMID 35162339 · DOI
  5. Morgan CA 3rd et al. , 1993.

Caffeine

FDA status: FDA has approved products that contain caffeine, including Cafergot.

PubMed: 37,330 publications mention Caffeine, 2,721 of them trials or reviews. Search PubMed

  1. The effect of caffeine on subsequent sleep: A systematic review and meta-analysis. Gardiner C et al. Sleep medicine reviews, 2023. Meta-Analysis, Systematic Review. PMID 36870101 · DOI
  2. Effects of Caffeine Intake on Endurance Running Performance and Time to Exhaustion: A Systematic Review and Meta-Analysis. Wang Z et al. Nutrients, 2022. Meta-Analysis, Systematic Review. PMID 36615805 · DOI
  3. Energy Drinks and Their Adverse Health Effects: A Systematic Review and Meta-analysis. Nadeem IM et al. Sports health, 2021. Meta-Analysis, Systematic Review. PMID 33211984 · DOI
  4. Coffee, caffeine, and sleep: A systematic review of epidemiological studies and randomized controlled trials. Clark I et al. Sleep medicine reviews, 2017. Systematic Review. PMID 26899133 · DOI

DHEA

FDA status: We found no FDA-approved drug product listing dhea as an active ingredient in openFDA.

PubMed: 8,387 publications mention DHEA, 557 of them trials or reviews. Search PubMed

ClinicalTrials.gov: 163 registered studies. See all studies

  • NCT07407647 Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer (Phase 2), recruiting

MedlinePlus drug information ↗RxNorm 3143 ↗PubChem CID 5881 ↗Wikipedia ↗

Cyanocobalamin

FDA status: FDA has approved products that contain cyanocobalamin, including Infuvite Pediatric, Nascobal.

PubMed: 1,669 publications mention Cyanocobalamin, 87 of them trials or reviews. Search PubMed

  1. Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease. Christine CW et al. Movement disorders : official journal of the Movement Disorder Society, 2018. Randomized Controlled Trial. PMID 29508904 · DOI
  2. Systematic review and meta-analysis of randomized placebo-controlled trials of folate and vitamin B12 for depression. Almeida OP et al. International psychogeriatrics, 2015. Meta-Analysis, Systematic Review. PMID 25644193 · DOI
  3. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Eussen SJ et al. Archives of internal medicine, 2005. Clinical Trial, Randomized Controlled Trial. PMID 15911731 · DOI
  4. Association Between Folic Acid Prescription Fills and Suicide Attempts and Intentional Self-harm Among Privately Insured US Adults. Gibbons RD et al. JAMA psychiatry, 2022. Randomized Controlled Trial.

Methionine

FDA status: FDA has approved products that contain methionine, including Aminosyn Ii, Aminosyn-Pf, Clinimix, Kabiven.

PubMed: 61,633 publications mention Methionine, 806 of them trials or reviews. Search PubMed

  1. Evaluation of dietary protein and amino acid requirements: a systematic review. Burstad KM et al. The American journal of clinical nutrition, 2025. Systematic Review. PMID 40610129 · DOI
  2. Interventions for paracetamol (acetaminophen) overdose. Chiew AL et al. The Cochrane database of systematic reviews, 2018. Meta-Analysis, Systematic Review. PMID 29473717 · DOI
  3. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. Morris AA et al. Journal of inherited metabolic disease, 2017. Systematic Review. PMID 27778219 · DOI
  4. The concept of folic acid supplementation and its role in prevention of neural tube defect among pregnant women: PRISMA. Seyoum Tola F et al. Medicine, 2024. Systematic Review. PMID 38728462 · DOI

Inositol

FDA status: We found no FDA-approved drug product listing inositol as an active ingredient in openFDA.

PubMed: 43,592 publications mention Inositol, 458 of them trials or reviews. Search PubMed

  1. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. Fitz V et al. The Journal of clinical endocrinology and metabolism, 2024. Systematic Review, Meta-Analysis. PMID 38163998 · DOI
  2. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Greff D et al. Reproductive biology and endocrinology : RB&E, 2023. Meta-Analysis, Systematic Review. PMID 36703143 · DOI
  3. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. Sarris J et al. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2022. Meta-Analysis. PMID 35311615 · DOI
  4. Nutrition and bipolar disorder: a systematic review. Gabriel FC et al. , 2023.

Chromium

FDA status: We found no FDA-approved drug product listing chromium as an active ingredient in openFDA.

PubMed: 37,431 publications mention Chromium, 784 of them trials or reviews. Search PubMed

  1. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials. Xia J et al. Pharmacological research, 2023. Systematic Review, Network Meta-Analysis. PMID 36638933 · DOI
  2. Chromium supplementation and type 2 diabetes mellitus: an extensive systematic review. Georgaki MN et al. Environmental geochemistry and health, 2024. Systematic Review. PMID 39541030 · DOI
  3. Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis. Zhao F et al. Biological trace element research, 2022. Meta-Analysis, Systematic Review. PMID 33783683 · DOI
  4. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Asbaghi O et al. Pharmacological research, 2020.

Sources checked October 22, 2026. Listing a study is not a claim that this product is safe or effective for you; a licensed clinician makes that decision.

Patient reviews

Reviews come only from patients who received Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule through UpLiftRX. Each is checked for privacy and safety before it's published; we never remove a review for being negative. Individual experiences vary, and reviews aren't medical advice.

No reviews yet. Patients who receive Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule through UpLiftRX can leave a review after delivery.

For patients who received Naltrexone + Yohimbine + Caffeine + DHEA + Cyanocobalamin + Methionine + Inositol + Chromium Capsule.
Yohimbine-facilitated acoustic startle reflex in humans.
Psychopharmacology
Clinical Trial, Randomized Controlled Trial.
PMID 7831429
· DOI

ClinicalTrials.gov: 51 registered studies. See all studies

  • NCT01031979 Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine (Phase 2), completed

RxNorm 220982 ↗PubChem CID 8969 ↗Wikipedia ↗

  • The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials. Tabrizi R et al. Critical reviews in food science and nutrition, 2019. Meta-Analysis, Systematic Review. PMID 30335479 · DOI
  • ClinicalTrials.gov: 1,236 registered studies. See all studies

    • NCT03367806 Caffeine Consumption and Mortality in Diabetes, completed

    FDA label (DailyMed) ↗RxNorm 1886 ↗PubChem CID 2519 ↗Wikipedia ↗

    PMID 36169979
    · DOI
  • Effect of two different sublingual dosages of vitamin B(12) on cobalamin nutritional status in vegans and vegetarians with a marginal deficiency: A randomized controlled trial. Del Bo' C et al. Clinical nutrition (Edinburgh, Scotland), 2019. Randomized Controlled Trial. PMID 29499976 · DOI
  • ClinicalTrials.gov: 760 registered studies. See all studies

    MedlinePlus drug information ↗RxNorm 11248 ↗PubChem CID 166596686 ↗Wikipedia ↗

  • Difference between kwashiorkor and marasmus: Comparative meta-analysis of pathogenic characteristics and implications for treatment. Pham TP et al. Microbial pathogenesis, 2021. Meta-Analysis, Review. PMID 33359074 · DOI
  • ClinicalTrials.gov: 213 registered studies. See all studies

    RxNorm 6837 ↗PubChem CID 6137 ↗Wikipedia ↗

    Nutritional neuroscience
    Systematic Review.
    PMID 35608150
    · DOI
  • Polycystic ovaries and herbal remedies: A systematic review. Manouchehri A et al. JBRA assisted reproduction, 2023. Systematic Review. PMID 35916457 · DOI
  • ClinicalTrials.gov: 195 registered studies. See all studies

    • NCT05701813 The Study Aims to Investigate the Effects of Oral Inositols on Insulin-resistance in Children With Obesity., unknown

    RxNorm 5833 ↗PubChem CID 892 ↗Wikipedia ↗

    Meta-Analysis, Systematic Review.
    PMID 32730903
    · DOI
  • Therapeutic effects of chromium supplementation on women with polycystic ovarian syndrome: A systematic review and meta-analysis. Hamsho M et al. Endocrinologia, diabetes y nutricion, 2025. Meta-Analysis, Systematic Review. PMID 41067797 · DOI
  • ClinicalTrials.gov: 315 registered studies. See all studies

    RxNorm 2496 ↗PubChem CID 23976 ↗Wikipedia ↗